Norway appoints new wealth fund supervisor at central bank – Reuters
Norway has appointed Oeystein Boersum as deputy governor and executive board member of its central bank, with a dedicated
recent post
-
Dec 20 2025 -
Dec 20 2025
-
Dec 20 2025
-
Dec 20 2025 -
Dec 20 2025
Don’t fear inflation
Inflation isn’t always and necessarily a bad thing. It’s one of many variables in the economy, and its presence
Alibaba rival JD raises more than $10 billion through stock offerings in a single year
In less than a year, Chinese e-commerce giant JD.com has raised more than $10 billion through public offerings in
The Weekly Fix: Half-Trillion Traffic Jam; Reddit’s AMC Rescue
Welcome to the Weekly Fix, the newsletter that’s trying to clean up its capital structure. I’m cross-asset reporter Katie Greifeld.
David Rosenberg: A change is gonna come: Why the TINA trade is losing its mojo
By David Rosenberg and Brendan Livingstone One of the common criticisms we hear
This Bitcoin bear market will be good for builders and bad for speculators.
Yes, I think Bitcoin (and other crypto) is in a bear market. I have no idea how low we
VNQ: A Safe And Rising 3% Dividend Yield Backed By Real Estate Inflation
VNQ is a diversified play on quickly escalating real estate pricing in America. Read more about the ETF’s performance
Telefonica Still Looks Undervalued
Telefonica trades at a forward price-to-earnings ratio of 10.4. Click here to read why the stock is still undervalued.
China stocks post best week in 3 months on easing inflation fears, yuan strength
The blue-chip CSI300 index fell 0.3 per cent to 5,321.09, while the Shanghai Composite Index eased 0.2 per cent
Buy Sun Pharmaceutical; target of Rs 786: Dolat Capital Market
Dolat Capital Market is bullish on Sun Pharmaceutical has recommended buy rating on the stock with a target price